程華珍
【摘 要】目的:研究不同的治療方案用于治療婦產(chǎn)科宮頸糜爛患者的臨床療效。方法:在我院婦產(chǎn)科室2016年6月至2018年10月期間收治的宮頸糜爛患者中,隨機擇取120例患者作為研究對象,根據(jù)治療方式不同將其隨機分為兩組。研究組接受激光治療和藥物治療聯(lián)合方案,參照組則僅接受藥物治療,對比兩組患者接受治療后的療效。結果:研究組患者陰道停止?jié)B液的時間以及癥狀改善的時間均顯著短于參照組患者,兩組間差異有統(tǒng)計學意義(P<0.05);研究組患者使用聯(lián)合療法后總的治療有效率顯著高于參照組患者,兩組間差異有統(tǒng)計學意義(P<0.05);研究組患者發(fā)生并發(fā)癥幾率與復發(fā)率均低于參照組患者,兩組間差異有統(tǒng)計學意義(P<0.05)。結論:婦產(chǎn)科室收治宮頸糜爛患者后,可優(yōu)先采取激光療法聯(lián)合藥物治療的綜合治療方式,可顯著提升患者的治療有效率。
【關鍵詞】聯(lián)合治療方式;激光治療;藥物治療;治療效果;并發(fā)癥發(fā)生率
Abstract Objective: To study the clinical efficacy of different treatment regimens in the treatment of cervical erosion in obstetrics and gynecology. Methods: Among the patients with cervical erosion who were admitted to the Department of Obstetrics and Gynecology in our hospital from June 2016 to October 2018, 120 patients were randomly selected as subjects, and they were randomly divided into two groups according to different treatment methods. The study group received a combination of laser therapy and drug therapy, while the reference group received only drug therapy, comparing the efficacy of the two groups of patients after treatment.RESULTS: The time to vaginal effusion and the time to symptom improvement were significantly shorter in the study group than in the reference group. The difference between the two groups was statistically significant (P<0.05). The total effective rate of the treatment group was combined with the combination therapy. There was significant difference between the two groups (P<0.05). The incidence of complications and recurrence rate in the study group were lower than those in the reference group. The difference between the two groups was statistically significant (P<0.05).). Conclusion: After the treatment of cervical erosion in the obstetrics and gynecology department, the comprehensive treatment of microwave therapy combined with drug therapy can be given priority, which can significantly improve the treatment efficiency of patients.
Key words: combination therapy; Laser Treatment; drug therapy; therapeutic effect; complication rate
【中圖分類號】 R729
【文獻標識碼】 A【文章編號】 1672-3783(2019)04-03-018-01
當前宮頸糜爛的發(fā)病群體年齡有低齡化的趨勢,存在不潔性行為和衛(wèi)生習慣不佳會增加宮頸糜爛的患病風險。中年已婚女性是宮頸糜爛疾病的高危人群,發(fā)病期間會出現(xiàn)白帶異常、生理期外陰道發(fā)生不規(guī)則出血以及生理期疼痛等癥狀[1]。若患者發(fā)病后治療不及時,泌尿系統(tǒng)感染風險劇增,且隨著病情進一步惡化,患者的生育功能也會受到嚴重影響造成不孕不育。本文主要研究使用不同的治療方式治療宮頸糜爛的療效,特選取120例患者作為研究對象,使用隨機數(shù)表均分為兩組后進行研究,現(xiàn)將研究過程作以下詳細報道:
1 資料和方法
1.1 一般資料
在我院婦產(chǎn)科室2016年6月至2018年10月期間收治的宮頸糜爛患者中,隨機擇取120例患者作為研究對象,根據(jù)治療方式不同將其隨機分為兩組。納入標準:確診為宮頸糜爛疾病;未發(fā)生陰道感染;無惡性腫瘤疾病;精神狀態(tài)正常;心肺功能正常。研究組60例患者年齡為(23~50)歲,平均年齡為(34.28±2.26)歲,病程為(1~8)年,平均病程為(4.62±1.53)年;參照組60例患者年齡為(24~49)歲,平均年齡為(34.19±2.28)歲,病程為(1~9)年,平均病程為(4.91±1.47)年。兩組患者在年齡、病程以及宮頸糜爛分級方面并無顯著差異,無統(tǒng)計學意義(P>0.05),有同期比較價值。所有患者和家屬均已了解治療方案并同意接受治療,同意簽訂知情書。本次開展研究項目已向上級領導和院辦領導報告,下發(fā)有正式審批文件。